Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonia | 17 | 2024 | 2154 | 2.930 |
Why?
|
Community-Acquired Infections | 11 | 2024 | 465 | 2.090 |
Why?
|
Lyme Disease | 7 | 2019 | 621 | 1.820 |
Why?
|
Appendicitis | 4 | 2022 | 671 | 1.490 |
Why?
|
Pneumonia, Bacterial | 3 | 2020 | 318 | 1.270 |
Why?
|
Immunoenzyme Techniques | 4 | 2019 | 1798 | 1.240 |
Why?
|
Radiography, Thoracic | 5 | 2022 | 1279 | 1.040 |
Why?
|
Retropharyngeal Abscess | 1 | 2021 | 21 | 0.770 |
Why?
|
Serologic Tests | 3 | 2019 | 378 | 0.760 |
Why?
|
Pharyngeal Diseases | 1 | 2021 | 135 | 0.700 |
Why?
|
Antifibrinolytic Agents | 1 | 2021 | 259 | 0.660 |
Why?
|
Immunoblotting | 2 | 2019 | 1675 | 0.650 |
Why?
|
Thorax | 1 | 2022 | 550 | 0.650 |
Why?
|
Respiratory Tract Infections | 3 | 2021 | 980 | 0.640 |
Why?
|
Eye Injuries | 1 | 2021 | 244 | 0.630 |
Why?
|
Ovariectomy | 1 | 2020 | 665 | 0.630 |
Why?
|
Dacryocystitis | 1 | 2018 | 69 | 0.610 |
Why?
|
Nasolacrimal Duct | 1 | 2018 | 75 | 0.610 |
Why?
|
Radius | 1 | 2020 | 438 | 0.600 |
Why?
|
Flushing | 1 | 2017 | 49 | 0.590 |
Why?
|
Anti-Bacterial Agents | 13 | 2024 | 7269 | 0.560 |
Why?
|
Radiography | 5 | 2023 | 7047 | 0.550 |
Why?
|
Communicable Diseases | 2 | 2023 | 892 | 0.540 |
Why?
|
Educational Measurement | 1 | 2022 | 1221 | 0.520 |
Why?
|
Bacteremia | 2 | 2019 | 961 | 0.520 |
Why?
|
Wounds, Nonpenetrating | 1 | 2021 | 799 | 0.500 |
Why?
|
Child | 36 | 2024 | 78594 | 0.500 |
Why?
|
Radius Fractures | 1 | 2020 | 508 | 0.490 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 795 | 0.490 |
Why?
|
Appendectomy | 4 | 2022 | 426 | 0.470 |
Why?
|
Mediastinal Neoplasms | 1 | 2017 | 421 | 0.470 |
Why?
|
Child, Preschool | 19 | 2022 | 41390 | 0.430 |
Why?
|
Back Pain | 1 | 2016 | 546 | 0.430 |
Why?
|
Emergency Service, Hospital | 12 | 2023 | 7766 | 0.390 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2011 | 40 | 0.380 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1651 | 0.380 |
Why?
|
Exophthalmos | 1 | 2011 | 97 | 0.370 |
Why?
|
Laparoscopy | 1 | 2022 | 2145 | 0.370 |
Why?
|
Abdominal Pain | 1 | 2016 | 1062 | 0.360 |
Why?
|
Neuroblastoma | 1 | 2017 | 1242 | 0.330 |
Why?
|
Infant | 16 | 2023 | 35447 | 0.320 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3885 | 0.320 |
Why?
|
Hospitals, Pediatric | 5 | 2023 | 1791 | 0.310 |
Why?
|
Borrelia burgdorferi | 3 | 2019 | 179 | 0.310 |
Why?
|
Antibodies, Bacterial | 3 | 2019 | 1475 | 0.300 |
Why?
|
Respiratory Sounds | 2 | 2022 | 696 | 0.270 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 690 | 0.250 |
Why?
|
Immunoglobulin M | 3 | 2019 | 1537 | 0.240 |
Why?
|
Sensitivity and Specificity | 7 | 2019 | 14761 | 0.240 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3871 | 0.230 |
Why?
|
Adolescent | 17 | 2023 | 86713 | 0.220 |
Why?
|
Humans | 45 | 2024 | 752741 | 0.220 |
Why?
|
Cohort Studies | 8 | 2022 | 40939 | 0.210 |
Why?
|
Hyphema | 1 | 2021 | 27 | 0.200 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2021 | 50 | 0.190 |
Why?
|
Pediatrics | 1 | 2016 | 3517 | 0.190 |
Why?
|
Hospitalization | 7 | 2023 | 10422 | 0.190 |
Why?
|
Retrospective Studies | 15 | 2023 | 78758 | 0.180 |
Why?
|
Acute Disease | 2 | 2022 | 7221 | 0.180 |
Why?
|
Fever | 3 | 2023 | 1627 | 0.180 |
Why?
|
Ambulatory Care | 2 | 2021 | 2738 | 0.170 |
Why?
|
Complement C6 | 1 | 2018 | 21 | 0.170 |
Why?
|
Male | 22 | 2022 | 354311 | 0.170 |
Why?
|
Female | 22 | 2022 | 385090 | 0.160 |
Why?
|
Seasons | 2 | 2023 | 1511 | 0.160 |
Why?
|
Viruses | 1 | 2022 | 377 | 0.160 |
Why?
|
Pseudomonas Infections | 1 | 2022 | 608 | 0.150 |
Why?
|
Orchitis | 1 | 2017 | 35 | 0.150 |
Why?
|
Epididymitis | 1 | 2017 | 37 | 0.150 |
Why?
|
Spermatic Cord Torsion | 1 | 2017 | 73 | 0.140 |
Why?
|
False Positive Reactions | 2 | 2016 | 965 | 0.140 |
Why?
|
Neck | 1 | 2021 | 713 | 0.140 |
Why?
|
Leukocyte Count | 1 | 2019 | 1604 | 0.130 |
Why?
|
False Negative Reactions | 1 | 2016 | 587 | 0.130 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 25454 | 0.120 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1184 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1270 | 0.110 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15164 | 0.110 |
Why?
|
Treatment Outcome | 5 | 2022 | 64017 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2019 | 1011 | 0.110 |
Why?
|
Eye Hemorrhage | 1 | 2011 | 19 | 0.100 |
Why?
|
Lung Diseases | 1 | 2022 | 1890 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2017 | 2978 | 0.100 |
Why?
|
Ophthalmoscopy | 1 | 2011 | 177 | 0.100 |
Why?
|
Infant, Newborn | 3 | 2020 | 25903 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2019 | 4575 | 0.090 |
Why?
|
Prospective Studies | 5 | 2022 | 53863 | 0.090 |
Why?
|
Incidence | 2 | 2020 | 21146 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1459 | 0.090 |
Why?
|
Logistic Models | 2 | 2022 | 13441 | 0.090 |
Why?
|
Algorithms | 2 | 2019 | 13984 | 0.080 |
Why?
|
Penicillins | 2 | 2023 | 387 | 0.080 |
Why?
|
United States | 7 | 2022 | 70772 | 0.080 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 545 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3433 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4881 | 0.070 |
Why?
|
Risk Assessment | 2 | 2018 | 23554 | 0.070 |
Why?
|
Parents | 1 | 2020 | 3448 | 0.070 |
Why?
|
Caregivers | 1 | 2017 | 2149 | 0.070 |
Why?
|
Boston | 1 | 2017 | 9348 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2436 | 0.060 |
Why?
|
Risk Factors | 2 | 2022 | 73094 | 0.060 |
Why?
|
Chronic Disease | 1 | 2017 | 9223 | 0.050 |
Why?
|
Mycoplasma pneumoniae | 1 | 2021 | 43 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13042 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20346 | 0.050 |
Why?
|
Macrolides | 1 | 2021 | 203 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35798 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15459 | 0.040 |
Why?
|
Diagnostic Techniques, Respiratory System | 1 | 2019 | 12 | 0.040 |
Why?
|
Patient Discharge | 2 | 2023 | 3356 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7355 | 0.040 |
Why?
|
Computers | 1 | 2021 | 607 | 0.040 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
Patient Readmission | 2 | 2021 | 3161 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2022 | 1216 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2017 | 520 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3941 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2023 | 2295 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 57267 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4943 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8607 | 0.030 |
Why?
|
Contractile Proteins | 1 | 2012 | 246 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 1885 | 0.020 |
Why?
|
Physical Examination | 1 | 2017 | 1237 | 0.020 |
Why?
|
Metalloendopeptidases | 1 | 2012 | 404 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3558 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3986 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1152 | 0.020 |
Why?
|
Bacteria | 1 | 2017 | 2145 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2215 | 0.020 |
Why?
|
Ultrasonography | 1 | 2017 | 6037 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18460 | 0.010 |
Why?
|
Proteomics | 1 | 2012 | 3686 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39223 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15657 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 21904 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22009 | 0.010 |
Why?
|
Mice | 1 | 2012 | 81766 | 0.000 |
Why?
|
Animals | 1 | 2012 | 169600 | 0.000 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_